Document Detail


Inhibition of restriction endonuclease cleavage site via triple helix formation by homopyrimidine phosphorothioate oligonucleotides.
MedLine Citation:
PMID:  8240378     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The ability of pyrimidine rich oligonucleotide phosphorothioate to form stable triple helical structures with the sequence containing the recognition site for the class II-S restriction enzyme Ksp 632-I was examined. First, we synthesized double strand oligonucleotides corresponding to the SV40 sites and studied their interaction with homopyrimidine oligodeoxyribonucleotides including replacement of the other chain either PS group (SO-ODNs) in second nucleotide position (from 5'-terminus) and end capped with the PS group at both 3'- and 5'-ends (S2O-ODNs). The resulting perfect DNA triplexes were detected by gel-mobility shift. The phosphorothioate oligonucleotide analogues (SO-ODNs) and (S2O-ODNs) were shown to inhibit enzymatic cleavage under conditions that allow for triple helix formation. Inhibition is sequence-specific and occurs in the micromolar concentration range. Of particular interest is the Sp-phosphorothioate analogue (Sp-SO-ODNs) which inhibited endonuclease more than the other phosphorothioate oligonucleotide analogues (Rp-SO-ODNs or S2O-ODNs).
Authors:
S Tsukahara; S G Kim; H Takaku
Related Documents :
10458798 - Photoregulation of the formation and dissociation of a dna duplex by using the cis-tran...
8841588 - Properties of nicked and circular dumbbell rna-dna chimeric oligonucleotides.
19199568 - Statistically significant raman detection of midsequence single nucleotide polymorphisms.
17131448 - Dna-based phosphane ligands.
19053278 - Dodecamer dna duplex formation is characterized by second-order kinetics, positive acti...
10828048 - Acquired dna mutations associated with in vivo hydroxyurea exposure.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Biochemical and biophysical research communications     Volume:  196     ISSN:  0006-291X     ISO Abbreviation:  Biochem. Biophys. Res. Commun.     Publication Date:  1993 Oct 
Date Detail:
Created Date:  1993-12-09     Completed Date:  1993-12-09     Revised Date:  2008-08-26    
Medline Journal Info:
Nlm Unique ID:  0372516     Medline TA:  Biochem Biophys Res Commun     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  990-6     Citation Subset:  IM    
Affiliation:
Department of Industrial Chemistry, Chiba Institute of Technology, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Base Sequence
Deoxyribonucleases, Type II Site-Specific / antagonists & inhibitors*
Molecular Sequence Data
Oligodeoxyribonucleotides / pharmacology*
Pyrimidines
Structure-Activity Relationship
Substrate Specificity
Thionucleotides / pharmacology*
Chemical
Reg. No./Substance:
0/Oligodeoxyribonucleotides; 0/Pyrimidines; 0/Thionucleotides; EC 3.1.21.4/CCGCGG-specific type II deoxyribonucleases; EC 3.1.21.4/Deoxyribonucleases, Type II Site-Specific

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Expression of receptors for advanced glycosylation end products on renal cell carcinoma cells in vit...
Next Document:  Effects of tannic acid on 12-O-tetradecanoylphorbol-13-acetate-induced protein kinase C activation i...